Smith & Nephew PLC
SN.: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|@? | LOCK|@&r$ | LOCK|d@GSq?? |
Smith & Nephew Earnings: Steady Results Underscore the Firm's New Stability
Smith & Nephew reported abbreviated first-quarter performance that included consolidated revenue, orthopedic, and advanced wound care growth of 3%, 3%, and 8%, respectively (in constant currency).
